A Win For Veru Inc.
Mon, Apr 11, 2022 at 05:30 PM
Veru Inc. (VERU:NASDAQ) shot up at $12.28, a gain of 182.3%. On Fri, Apr 08, 2022, VERU:NASDAQ hit a New 2-Week Low of $4.35. The stock got featured on our News Catalysts scanner on Mon, Apr 11, 2022 at 04:46 PM in the 'MISCELLANEOUS' category. From Fri, Mar 25, 2022, the stock recorded 40.00% Up Days and 18.18% Green Days
About Veru Inc. (VERU:NASDAQ)
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.
Top 10 Gainers:
- Veru Inc. (VERU:NASDAQ), 182.3%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 71.57%
- Athersys, Inc. (ATHX:NASDAQ), 63%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 55.14%
- Genocea Biosciences, Inc. (GNCA:NASDAQ), 50%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 35.41%
- 21Vianet Group, Inc. (VNET:NASDAQ), 29.63%
- SailPoint Technologies Holdings, Inc. (SAIL:NYSE), 29.16%
- Reading International, Inc. (RDIB:NASDAQ), 25.54%
- 5E Advanced Materials Inc. (FEAM:NASDAQ), 24%